Updated News | Novartis provides update on EU marketing authorization application for RLX030 ... MarketWatch (Thomson Reuters ONE via COMTEX) -- Novartis International AG / Novartis provides update on EU marketing authorization application for RLX030 in acute heart failure . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely ... The EU's not impressed with Novartis' 'breakthrough' cardio drug, either |
